Edition:
India

GSK Says Intravenous Benlysta Is First Biologic Treatment To Be Approved For Children With Lupus In Europe


Tuesday, 29 Oct 2019 

Oct 29 (Reuters) - GlaxoSmithKline PLC ::GLAXOSMITHKLINE - INTRAVENOUS BENLYSTA IS FIRST BIOLOGIC TREATMENT TO BE APPROVED FOR CHILDREN WITH LUPUS IN EUROPE.GSK - EC DECIDED TO EXTEND TO CHILDREN 5 YRS & OLDER, EXISTING ADULT INDICATION FOR BELIMUMAB AS ADD-ON THERAPY IN PATIENTS WITH LUPUS.